# Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults

> **NCT00527046** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 396 (actual)

## Conditions studied

- Aging
- Frail Older Adults

## Interventions

- **DRUG:** CP-424,391

## Key facts

- **NCT ID:** NCT00527046
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-12
- **Primary completion:** 2001-10
- **Final completion:** 2001-10
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527046, "Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00527046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*